Ovarian Cancer Tests Flawed, in Need of New Design, Says Stanford Study

Ovarian Cancer Tests Flawed, in Need of New Design, Says Stanford Study: "Ovarian Cancer Tests Flawed, in Need of New Design, Says Stanford Study"

High-Resolution Genomic Profiling of Carboplatin Resistance in Early-Stage Epithelial Ovarian Carcinoma

2009 Newly and relapsed epithelial ovarian carcinoma: ESMOClinical Recommendations for diagnosis, treatment and follow-up

BioMed Central | Full text | Activity of chemotherapy in mucinous ovarian cancer with a recurrence free interval of more than 6 months: results from the SOCRATES retrospective study.

BioMed Central | Full text | Activity of chemotherapy in mucinous ovarian cancer with a recurrence free interval of more than 6 months: results from the SOCRATES retrospective study.: "Activity of chemotherapy in mucinous ovarian cancer with a recurrence free interval of more than 6 months: results from the SOCRATES retrospective study"

Chemoprevention in the Lynch Syndrome: What Can We Do?

Chemoprevention in the Lynch Syndrome: What Can We Do?

Survival in women with MMR mutations and ovarian cancer; A multicentre study in Lynch Syndrome kindreds